YT3-19477-68662
2 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 190 / PA
- Registered
- 2021-09-22
- Relationship
- Child or adolescent in my care
- Guardian
- 9K2-84929-07163
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-04
Dose 1 — Pfizer-BioNTech
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-09-22
Registered in v-safe
- 2021-10-27
-
2022-04-27
Survey response — 12 months, dose 2, dependentMedDRA: Malaise — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2 days ago, she said declared she was sick and took to her bed. Yesterday she said she was better, today: still under the weather but reports that she feels better. At no time has she run a fever.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-04 | Pfizer-BioNTech | No |
| 2 | 2021-04-27 | Pfizer-BioNTech | No |
Free text
Release 11 — 12 months, dose 2, dependent
Symptoms: 2 days ago, she said declared she was sick and took to her bed. Yesterday she said she was better, today: still under the weather but reports that she feels better. At no time has she run a fever.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Malaise | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release